Objectives: Insulin autoimmune syndrome (IAS) is an extremely rare cause of hypoglycemia, particularly in non-Asian populations. Methods: In this report, we describe a white male patient with elevated total insulin (>100.0 µIU/mL), C-peptide, and proinsulin levels who was diagnosed with IAS due to anti-insulin antibodies. He also had a small IgG к M-protein. Results: We show that anti-insulin antibodies and/or the monoclonal protein can significantly interfere with insulin and C-peptide immunoassays and propose polyethylene glycol precipitation to quantitate free C-peptide levels as a useful assay in differentiating IAS due to anti-insulin antibodies from insulinoma. Conclusions: In patients presenting with hypoglycemi
Aims: Anti‐insulin antibodies in insulin‐treated diabetes can derange glycaemia, but are under‐recog...
This is the author accepted manuscript. The final version is available from the publisher via the DO...
Introduction: C-peptide is used as a marker of endogenous insulin secretion in the assessment of re...
CONTEXT: Insulin-binding antibodies may produce severe dysglycaemia in insulin-naïve patients ('insu...
Context: Insulin autoimmune syndrome (IAS), spontaneous hyperinsulinemic hypoglycemia due to insulin...
The definition of Insulin autoimmune syndrome includes the presence of high levels of blood insulin ...
On the basis of results of simultaneous determinations of plasma free insulin and free c-peptide, ep...
OBJECTIVE - To investigate whether the presence of antibody markers at diagnosis could help predict ...
Funder: Diabetes Research & Wellness Foundation; doi: http://dx.doi.org/10.13039/501100000273Funder:...
Factitious hyperinsulinism was suspected in a patient with an 11-year history of insulin-dependent, ...
International audienceInsulin-antibodies are a cause of misleading results in insulin immunoassays. ...
Impaired beta-cell function is a recognized cornerstone of diabetes pathophysiology. Estimates of in...
Insulin antibodies (IA) associated with exogenous insulin administration seldom caused hypoglycemia ...
OBJECTIVES: Blood insulin and C-peptide are key investigations in the differential diagnosis of hypo...
INTRODUCTION: C-peptide is an important marker to assess residual insulin production in individuals ...
Aims: Anti‐insulin antibodies in insulin‐treated diabetes can derange glycaemia, but are under‐recog...
This is the author accepted manuscript. The final version is available from the publisher via the DO...
Introduction: C-peptide is used as a marker of endogenous insulin secretion in the assessment of re...
CONTEXT: Insulin-binding antibodies may produce severe dysglycaemia in insulin-naïve patients ('insu...
Context: Insulin autoimmune syndrome (IAS), spontaneous hyperinsulinemic hypoglycemia due to insulin...
The definition of Insulin autoimmune syndrome includes the presence of high levels of blood insulin ...
On the basis of results of simultaneous determinations of plasma free insulin and free c-peptide, ep...
OBJECTIVE - To investigate whether the presence of antibody markers at diagnosis could help predict ...
Funder: Diabetes Research & Wellness Foundation; doi: http://dx.doi.org/10.13039/501100000273Funder:...
Factitious hyperinsulinism was suspected in a patient with an 11-year history of insulin-dependent, ...
International audienceInsulin-antibodies are a cause of misleading results in insulin immunoassays. ...
Impaired beta-cell function is a recognized cornerstone of diabetes pathophysiology. Estimates of in...
Insulin antibodies (IA) associated with exogenous insulin administration seldom caused hypoglycemia ...
OBJECTIVES: Blood insulin and C-peptide are key investigations in the differential diagnosis of hypo...
INTRODUCTION: C-peptide is an important marker to assess residual insulin production in individuals ...
Aims: Anti‐insulin antibodies in insulin‐treated diabetes can derange glycaemia, but are under‐recog...
This is the author accepted manuscript. The final version is available from the publisher via the DO...
Introduction: C-peptide is used as a marker of endogenous insulin secretion in the assessment of re...